Artivion | CRY - Loan Capital


Artivion reported $215.35M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 215.35M 2.46M Mar/2026
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 1.83B 29.45M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 221.33M 46.88M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
ResMed USD 404.17M 245K Mar/2026
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.67M 116K Jun/2025
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Terumo JPY 99.91B 13M Mar/2026
Trinity Biotech USD 114.86M 4.81M Sep/2025